Last reviewed · How we verify

NCT04206774

BIO|STREAM.ICM France

Completed Last updated 4 January 2022
What this trial tests

trial in Syncope in 92 participants. Completed in 16 December 2021.

Timeline
13 March 2020
Primary endpoint
1 July 2021
16 December 2021

Quick facts

Lead sponsorBiotronik SE & Co. KG
StatusCompleted
Study typeOBSERVATIONAL
Enrollment92
Start date13 March 2020
Primary completion1 July 2021
Estimated completion16 December 2021
Sites3 locations across France

Conditions studied

Sponsor

Biotronik SE & Co. KG — full company profile →

Who can join

18 and older, any sex, with Syncope or Cryptogenic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of the BIO│STREAM.ICM France submodule is to provide clinical evidence from patients in France on safety and efficacy of the BIOMONITOR system

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Syncope

Currently open trials in the same condition.

Other Biotronik SE & Co. KG trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04206774.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing